Search results for "Relative risk"

showing 10 items of 303 documents

The impact of antiviral therapy on the course of chronic HCV infection: A systematic review

2003

Aim. Chronic hepatitis C is a progressive disease that leads to liver cirrhosis and hepatocellular carcinoma in a period ranging from 10 to 30 y. Many factors have been related to disease progression and, among them, persistent HCV replication has been advocated as one of the major determinant of hepatic deterioration. With this respect any treatment of chronic hepatitis C is mainly aimed to reduce necro-inflammation by suppressing viral activity in the long-term. We evaluated the persistence of HCV clearance after interferon therapy during follow-up in patients considered as long-term responders. Secondly, we analyzed the rate of progression from hepatitis to cirrhosis and hepatocellular c…

Hepatitismedicine.medical_specialtyCirrhosisHepatologybusiness.industrymedicine.diseaseGastroenterologyPersistence (computer science)InterferonRelative riskInternal medicineHepatocellular carcinomaMedicineDecompensationbusinessProgressive diseasemedicine.drug
researchProduct

Desigualdades y mortalidad por cirrosis en varones (Zaragoza, 1996-2003)

2011

ResumenObjetivosAnalizar diferencias geográficas en la mortalidad por cirrosis hepática, en varones, en la provincia de Zaragoza, y su posible asociación con indicadores socioeconómicos, así como identificar la adecuación, en el ámbito rural, del índice de privación del proyecto MEDEA.MétodosLa unidad geográfica de análisis para Zaragoza capital fue la sección censal, y para el resto de la provincia el municipio. Para cada unidad de análisis se calculó la razón de mortalidad estandarizada cruda y suavizada mediante un modelo lineal generalizado mixto bayesiano. Se calculó un índice sintético de privación y se incluyó en el modelo en cuartiles. También se realizó el análisis exploratorio inc…

Index (economics)business.industryPublic Health Environmental and Occupational HealthCirrosis hepáticaCensusQuartileRelative riskMixed linear modelMortalidadLiver cirrhosisCredible intervalRuralidadMedicineRuralDesigualdadesRural areaMortalityInequalitiesbusinessSocioeconomic statusDemographyGaceta Sanitaria
researchProduct

Supplemental Perioperative Oxygen and the Risk of Surgical Wound Infection: A Randomized Controlled Trial

2006

ABSTRACT Three hundred patients were enrolled in a double-blind, randomized, controlled study designed to investigate the ability of supplemental perioperative oxygen to reduce wound infection. Participants were age 18 to 80 years, had no coexisting serious medical conditions, and were scheduled to undergo elective colorectal surgery at one of 14 participating hospitals in Spain. No patients undergoing minor or laparoscopic surgery were included. Anesthesia and antibiotic prophylaxis were standardized for the study. Patients were randomized by computer-generated codes to receive an oxygen/air mixture of 30% or 80% fraction of inspired oxygen (F102) intraoperatively and postoperatively for 6…

Laparoscopic surgerymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentObstetrics and GynecologySurgical woundGeneral MedicinePerioperativeColorectal surgerySurgerylaw.inventionRandomized controlled triallawFraction of inspired oxygenRelative riskmedicineAntibiotic prophylaxisbusinessObstetrical & Gynecological Survey
researchProduct

Survival time and differences between dementia with Lewy bodies and Alzheimer’s disease following diagnosis: a meta-analysis of longitudinal studies.

2019

Objective: To synthesize the evidence across longitudinal studies comparing survival in dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Methods: We conducted a systematic review and meta-analysis of studies comparing survival in clinically diagnosed DLB to AD. Longitudinal cohort studies were identified through a systematic search of major electronic databases from inception to May 2018. A random effects meta-analysis was performed to calculate survival time and relative risk of death. Results: Overall, 11 studies were identified including 22,952 patients with dementia: 2029 with DLB (mean diagnosis age 76.3; 47% female) compared with 20,923 with AD (mean diagnosis age 77.2; 6…

Lewy Body DiseaseMale0301 basic medicineAgingmedicine.medical_specialtyDiseaseBiochemistryLewy bodie03 medical and health sciences0302 clinical medicineA meta-analysis of longitudinal studies.- Ageing research reviews cilt.50 ss.72-80 2019 [MUELLER C. Soysal P. RONGVE A. ISIK A. THOMPSON T. MAGGI S. SMITH L. Basso C. STEWART R. BALLARD C. et al. -Survival time and differences between dementia with Lewy bodies and Alzheimer-s disease following diagnosis]Alzheimer DiseaseInternal medicinemental disordersmedicineHumansDementiaLongitudinal StudiesLongitudinal cohortMortalityMolecular BiologyAgedDementia with Lewy bodiesbusiness.industryCognitive scoreAlzheimer's diseaseRandom effects modelmedicine.diseaseSurvival RateObservational Studies as Topic030104 developmental biologyNeurologyMeta-analysisRelative riskFemaleDementiabusinessLewy bodiesAlzheimer’s disease030217 neurology & neurosurgeryBiotechnology
researchProduct

Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis

2013

Summary Background Propranolol is recommended for prophylaxis of variceal bleeding in cirrhosis. Carvedilol is a nonselective beta-blocker with a mild anti-alfa-1-adrenergic activity. Several studies have compared carvedilol and propranolol, yielding inconsistent results. Aim To perform a systematic review and meta-analysis of the randomised clinical trials comparing carvedilol with propranolol for hepatic vein pressure gradient reduction. Methods Studies were searched on the MEDLINE, EMBASE and Cochrane library databases up to November 2013. The weighted mean difference in percent hepatic vein pressure gradient reduction and the relative risk of failure to achieve a hemodynamic response (r…

Liver CirrhosisCirrhosisAdrenergic beta-AntagonistsCarbazolesPropranololHepatic VeinsCochrane LibraryPropanolaminesHypertension PortalmedicineHumansPharmacology (medical)Adverse effectCarvedilolHepatologybusiness.industryHemodynamicsGastroenterologymedicine.diseasePropranololMeta-analysisAnesthesiaRelative riskPortal hypertensionCarvedilolbusinessmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre…

2020

Background and aims: HCV is associated with an increased risk of cardiovascular events (CV). Whether HCV clearance by direct-acting antivirals (DAA) reduces incident CV disease is poorly understood. We investigate whether HCV eradication reduces CV events. Methods: In a prospective multicentre study, 2204 HCV patients (F0–F2:29.5%, F3–F4: 70.5%) were enrolled. Males were 48%, median age was 68 (59–74) years and BMI 25.9 (23.1–28); 24.7% were smokers, 18% had diabetes, 13.2% had cholesterol levels >200 mg/dl and 9.1% took statins, 44% had hypertension. During an overall median follow-up of 28 (24–39) months, incident CV events, such as ischemic heart disease (IHD) and ischemic cerebral st…

Liver CirrhosisMale0301 basic medicineCirrhosisMyocardial IschemiaComorbidityHepacivirusDisease030204 cardiovascular system & hematologyChronic hepatitis Cmedicine.disease_causechemistry.chemical_compound0302 clinical medicineRisk FactorsProspective StudiesIschemic heart disease Ischemic cerebral stroke Chronic hepatitis C CirrhosisIncidenceIncidence (epidemiology)SmokingMiddle AgedViral LoadStrokeItalyHypertensionFemaleCardiology and Cardiovascular MedicineDirect actingmedicine.medical_specialtyIschemic heart diseaseHepatitis C virusHypercholesterolemiaAntiviral Agents03 medical and health sciencesDiabetes mellitusInternal medicineDiabetes MellitusmedicineHumansViremiaAgedCirrhosibusiness.industryCholesterolHepatitis C Chronicmedicine.disease030104 developmental biologychemistryRelative riskIschemic cerebral strokeHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessAtherosclerosis
researchProduct

Survival and prognostic indicators in compensated and decompensated cirrhosis

1986

Six-year survival of cirrhosis was assessed in a series of 1155 consecutive patients (751 men, 404 women). Among the men, 33% were alcoholics and 18% were HBsAg positive; corresponding figures for the women were 15% and 6%, respectively. Features of decompensation at first presentation were observed in 63% of the patients. Six-year survival was 54% in compensated and 21% in decompensated patients. No significant differences in survival were found between alcoholics and nonalcoholics. Leading causes of death were liver failure (49%), hepatocellular carcinoma (22%), and bleeding (13%). The prognostic role of 21 variables was evaluated separately in compensated and decompensated patients by th…

Liver CirrhosisMaleRiskmedicine.medical_specialtyHBsAgCarcinoma HepatocellularCirrhosisPhysiologyGastroenterologySex FactorsEsophageal varicesLiver Cirrhosis AlcoholicInternal medicinemedicineHumansDecompensationProspective StudiesRetrospective StudiesProthrombin timeHepatitis B Surface Antigensmedicine.diagnostic_testbusiness.industryLiver NeoplasmsGastroenterologyMiddle AgedHepatologyPrognosismedicine.diseaseSurgeryHepatocellular carcinomaRelative riskRegression AnalysisFemalebusinessFollow-Up StudiesDigestive Diseases and Sciences
researchProduct

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta -Analysis

2020

Background & Aims:\ud Biopsy-confirmed liver fibrosis is a prognostic factor for patients with nonalcoholic fatty liver disease (NAFLD). We performed a systematic review to quantify the prognostic value of fibrosis stage in patients with NAFLD and the subgroup of patients with nonalcoholic steatohepatitis (NASH) and to assess the evidence that change in fibrosis stage is a surrogate endpoint.\ud \ud Methods:\ud We searched the MEDLINE, Embase, Cochrane Library, and trial registry databases through August 2018 for prospective or retrospective cohort studies of liver-related clinical events and outcomes in adults with NAFLD or NASH. We collected data on mortality (all cause and liver rela…

Liver Cirrhosismedicine.medical_specialtyBiopsyRisk AssessmentSeverity of Illness IndexLiver diseaseFibrosisNon-alcoholic Fatty Liver DiseaseInternal medicineNonalcoholic fatty liver diseasemedicineRisk of mortalityHumansHepatologybusiness.industrySurrogate endpointGastroenterologyKlinisk medicinRetrospective cohort studyConfounding Factors Epidemiologicmedicine.diseasePrognosisdigestive system diseasesLiverRelative riskMeta-analysisQuality of LifeClinical Medicinebusiness
researchProduct

Chronic high risk of intimate partner violence against women in disadvantaged neighborhoods: An eight-year space-time analysis

2020

Abstract We conducted a small-area ecological longitudinal study to analyze neighborhood contextual influences on the spatio-temporal variations in intimate partner violence against women (IPVAW) risk in a southern European city over an eight-year period. We used geocoded data of IPVAW cases with associated protection orders (n = 5867) in the city of Valencia, Spain (2011–2018). The city's 552 census block groups were used as the neighborhood units. Neighborhood-level covariates were: income, education, immigrant concentration, residential instability, alcohol outlet density, and criminality. We used a Bayesian autoregressive approach to spatio-temporal disease mapping. Neighborhoods with l…

Longitudinal studyEpidemiologymedia_common.quotation_subjectImmigrationSpecific riskIntimate Partner ViolenceNeighborhood DisadvantageVulnerable Populations01 natural sciences03 medical and health sciences0302 clinical medicineResidence CharacteristicsHumansMedicineLongitudinal Studies030212 general & internal medicineCities0101 mathematicsmedia_commonbusiness.industry010102 general mathematicsPublic Health Environmental and Occupational HealthBayes TheoremDisadvantagedSpainRelative riskDomestic violenceFemaleAlcohol outletbusinessDemographyPreventive Medicine
researchProduct

DOSE–RESPONSE RELATIONSHIPS BETWEEN WHOLE-BODY VIBRATION AND LUMBAR DISK DISEASE—A FIELD STUDY ON 388 DRIVERS OF DIFFERENT VEHICLES

1998

Abstract In a longitudinal study, the dose–response relationships between long term occupational exposure to whole-body vibration and degenerative processes in the lumbar spine caused by the lumbar disks were examined. From 1990 to 1992, 388 vibration-exposed workers from different driving jobs were examined medically and by lumbar X-ray. For each individual, a history of all exposure conditions was recorded, and a cumulative vibration dose was calculated allowing comparisons between groups of low, middle, and high intensity of exposure. 310 subjects were selected for a follow-up four years later, of whom 90·6% (n=281) agreed to participate. In comparing the exposure groups, the results ind…

Longitudinal studymedicine.medical_specialtyAcoustics and Ultrasonicsbusiness.industryMechanical EngineeringDiseaseCondensed Matter PhysicsLumbarMechanics of MaterialsRelative riskAnesthesiaEpidemiologyMedicineWhole body vibrationCumulative incidenceLumbar spinebusinessJournal of Sound and Vibration
researchProduct